Allied Market Research
Loading...
0
New
New

Animal Model Market by Animal Type (Rat, Mice, Guinea Pigs, Rabbits, and Others), Application (Drug Discovery & Development, Basic Research, and Others), and End User (Pharma & Biotech Companies, Academic Research Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A07946
Pages: 223
Jun 2021 | 990 Views
   
Author(s) : Sushant Terdale , Onkar Sumant
Tables: 126
Charts: 36
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Animal Model Market

Request Now !

The global animal model market was valued at $1,469 million in 2020, and is projected to reach $2,677 million by 2030, registering a CAGR of 6.1% from 2021 to 2030.

Animals and humans share common biological and physiological structures. Animals have shorter life cycle; however, they have high genotype resemblance. Animal models are progressively being used in biomedical research to develop novel treatment methods for various chronic diseases. Animal models provide better understanding of different chronic diseases along with the efficacy of medicinal drugs with regard to diseases. There are different types of animals used in animal models such as rat, mice, guinea pigs, rabbits, and others.

Get more information on this report: Request Sample Pages

Increase in demand for personalized medicines, rise in awareness among researchers about physiological similarities between humans & animals, surge in adoption of genetics in biomedical studies, and rise in usage of animal models in pre-clinical development by several research laboratories and biopharmaceutical industries are the major factors that are expected to drive the growth of the market. In addition, increase in government support for innovation & development of standard protocols allied with animal models, emergence of CRISPR as a powerful technology in the field of biomedical research, increase in need of animal models for production & quality control for therapeutic purpose, and rise in use of animal models in biomedical research, toxicology, physiology, cancer research, neurological research, genetic research, & xenotransplantation are expected to further drive the growth of the animal model market. However, regulations and laws for ethical use of animals in research are expected torestrain the growth of the animal model market. Conversely, growth opportunities in emerging markets are expected to offer lucrative opportunities during the forecast period.

The World Health Organization (WHO) on January 30th, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The COVID-19 pandemic is an unprecedented global public health challenge and is anticipated to have an important impact on the animal model market for R&D of vaccines and antiviral drugs. The large number of animal models is essential to verify the safety & efficacy of new entities before going for human trials. For instance, according to the WHO, nearly 20 vaccines are being developed globally for COVID-19. These COVID-19 vaccines are in the preclinical phase and some vaccines have already entered the animal trial phases. Some mice models have supported the replication of SARS-CoV-2 coronavirus such as 129SvEv, hACE2 transgenic, BALB/c, C57BL/6, and STA1 gene knockout (KO). Thus, COVID-19 infection uplifted growth and opportunities for key players of animal models during the forecast period.

Animal Model Market
By Animal Type

Your browser does not support the canvas element.

Rat segment is projected as one of the most lucRative segment.

Get more information on this report: Request Sample Pages

Animal Modelmarket Segmentation

The animal model market is segmented into animal type, application, end user, and region. On the basis of animal type, the market is categorized into rat, mice, guinea pigs, rabbits, and others. By application, the market is divided into drug discovery & development, basic research, and others. The drug discovery & development segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The basic research segment is further segmented by animal type such as rat, mice, guinea pigs, rabbits, and others. The others segment is further classified by animal type such as rat, mice, guinea pigs, rabbits, and others. By end user, the market is fragmented into pharma & biotech companies, academic research institutes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review

On the basis of animal type, the ratsegment is the major revenue contributor, and is projected to grow significantly during the forecast period. Increase in usage of rat models to study several complex disorders, rise in demand for rat model in biomedical research for understanding the existing health issues, increase in advancements in gene editing tools, surge in consumption of personalized medicine in developing & developed countries, continuous support by government in the form of investments & grants, technological advancements in gene editing tools, and increase in application of rat model in drug development and discovery are the major factors that drive the growth of the market.

Animal Model Market
By End User

Your browser does not support the canvas element.

Pharma and Biotech companies segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.

Get more information on this report: Request Sample Pages

By application, the drug discovery & development segment is the major shareholder in the animal model market, owing to increase in adoption of animal models in drug discovery & development along with production of novel products by pharmaceuticals & biotechnology companies and rise in preclinical activities and toxicity testing during drug development. In addition, upsurge in the discovery & development of new medicines and rise in R&D activities in the pharmaceuticals & biotech industry that need animal testing for ensuring safety & efficacy of drugs further drive the growth of the market.

Snapshot of Asia-Pacificanimal model market

Asia-Pacific presents lucrative opportunities for key players operating in the animal model market, owing to increase in number of initiatives and enhanced investments from governments for overall R&D of drugs using animal models and rise in implications of mouse clinical trials (MCTs) for more projecting outcomes In addition, ongoing innovations in animal models, availability of advanced healthcare systems, and significant surge in demand for advanced healthcare facilities contribute toward the growth of the market. Moreover, surge in focus of leading manufacturers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the animal model market in the region

Animal Model Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 7.3% during 2021-2030.

Get more information on this report: Request Sample Pages

The key players profiled in this report include Charles River Laboratories International, Inc, Envigo, Eurofins Scientific SE, GenOway S.A., Hera BioLabs (Transposagen Biopharmaceuticals), JSR Corporation (Crown Bioscience Inc.), Ozgene Pty Ltd., PerkinElmer, Inc. (Horizon Discovery Group plc.), Taconic Biosciences, and The Jackson Laboratory.

Key Benefits for Stakeholders: 

  • The study provides an in-depth analysis of the animal model market sizealong with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers animal model market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the globalanimal model market growth.

Key Market Segments: 

By Animal Type

  • Rat
  • Mice
  • Guinea Pigs
  • Rabbits
  • Others

By Application

  • Drug Discovery & Development
    • Rat
    • Mice
    • Guinea Pigs
    • Rabbits
    • Others
  • Basic Research
    • Rat
    • Mice
    • Guinea Pigs
    • Rabbits
    • Others
  • Others
    • Rat
    • Mice
    • Guinea Pigs
    • Rabbits
    • Others

By End User

  • Pharma & Biotech Companies
  • Academic Research Institutes
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments

1.3.1. List of key players profiled in the report

1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

CHAPTER 3: MARKET LANDSCAPE

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in usage of animal models in virology and infectious diseases
3.5.1.2. Increase in adoption of CRISPR technology
3.5.1.3. Upsurge in likelihood of epidemic or pandemic outbreaks

3.5.2. Restraint

3.5.2.1. Regulations and laws for ethical use of animals in research

3.5.3. Opportunity

3.5.3.1. Growth opportunities in emerging markets

3.5.4. Impact analysis

3.6. COVID-19 impact analysis on the animal model market

CHAPTER 4: ANIMAL MODEL MARKET, BY ANIMAL TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Rat

4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country

4.3. Mice

4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country

4.4. Guinea pigs

4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country

4.5. Rabbits

4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country

4.6. Others

4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country

CHAPTER 5: ANIMAL MODEL MARKET, BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Drug discovery & development

5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.2.4. Market size and forecast, by animal type

5.3. Basic research

5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.3.4. Market size and forecast, by animal type

5.4. Others

5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
5.4.4. Market size and forecast, by animal type

CHAPTER 6: ANIMAL MODEL MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Pharma & biotech companies

6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market analysis, by country

6.3. Academic research institutes

6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market analysis, by country

6.4. Others

6.4.1. Key market trends, growth factors, and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market analysis, by country

CHAPTER 7: ANIMAL MODEL MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country

7.2.2.1. U.S.

7.2.2.1.1. U.S. animal model market, by animal type
7.2.2.1.2. U.S. animal model market, by application
7.2.2.1.3. U.S. animal model market, by end user

7.2.2.2. Canada

7.2.2.2.1. Canada animal model market, by animal type
7.2.2.2.2. Canada animal model market, by application
7.2.2.2.3. Canada animal model market, by end user

7.2.2.3. Mexico

7.2.2.3.1. Mexico animal model market, by animal type
7.2.2.3.2. Mexico animal model market, by application
7.2.2.3.3. Mexico animal model market, by end user

7.2.3. North America market size and forecast, by animal type
7.2.4. North America market size and forecast, by application
7.2.5. North America market size and forecast, by end user

7.3. Europe

7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country

7.3.2.1. Germany

7.3.2.1.1. Germany animal model market, by animal type
7.3.2.1.2. Germany animal model market, by application
7.3.2.1.3. Germany animal model market, by end user

7.3.2.2. France

7.3.2.2.1. France animal model market, by animal type
7.3.2.2.2. France animal model market, by application
7.3.2.2.3. France animal model market, by end user

7.3.2.3. UK

7.3.2.3.1. UK animal model market, by animal type
7.3.2.3.2. UK animal model market, by application
7.3.2.3.3. UK animal model market, by end user

7.3.2.4. Italy

7.3.2.4.1. Italy animal model market, by animal type
7.3.2.4.2. Italy animal model market, by application
7.3.2.4.3. Italy animal model market, by end user

7.3.2.5. Spain

7.3.2.5.1. Spain animal model market, by animal type
7.3.2.5.2. Spain animal model market, by application
7.3.2.5.3. Spain animal model market, by end user

7.3.2.6. Rest of Europe

7.3.2.6.1. Rest of Europe animal model market, by animal type
7.3.2.6.2. Rest of Europe animal model market, by application
7.3.2.6.3. Rest of Europe animal model market, by end user

7.3.3. Europe market size and forecast, by animal type
7.3.4. Europe market size and forecast, by application
7.3.5. Europe market size and forecast, by end user

7.4. Asia-Pacific

7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country

7.4.2.1. Japan

7.4.2.1.1. Japan animal model market, by animal type
7.4.2.1.2. Japan animal model market, by application

7.4.2.1.3. Japan animal model market, by end user

7.4.2.2. China

7.4.2.2.1. China animal model market, by animal type
7.4.2.2.2. China animal model market, by application
7.4.2.2.3. China animal model market, by end user

7.4.2.3. Australia

7.4.2.3.1. Australia animal model market, by animal type
7.4.2.3.2. Australia animal model market, by application
7.4.2.3.3. Australia animal model market, by end user

7.4.2.4. India

7.4.2.4.1. India animal model market, by animal type
7.4.2.4.2. India animal model market, by application
7.4.2.4.3. India animal model market, by end user

7.4.2.5. South Korea

7.4.2.5.1. South Korea animal model market, by animal type
7.4.2.5.2. South Korea animal model market, by application
7.4.2.5.3. South Korea animal model market, by end user

7.4.2.6. Rest of Asia-Pacific

7.4.2.6.1. Rest of Asia-Pacific animal model market, by animal type
7.4.2.6.2. Rest of Asia-Pacific animal model market, by application
7.4.2.6.3. Rest of Asia-Pacific animal model market, by end user

7.4.3. Asia-Pacific market size and forecast, by animal type
7.4.4. Asia-Pacific market size and forecast, by application
7.4.5. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country

7.5.2.1. Brazil

7.5.2.1.1. Brazil animal model market, by animal type
7.5.2.1.2. Brazil animal model market, by application
7.5.2.1.3. Brazil animal model market, by end user

7.5.2.2. Saudi Arabia

7.5.2.2.1. Saudi Arabia animal model market, by animal type
7.5.2.2.2. Saudi Arabia animal model market, by application
7.5.2.2.3. Saudi Arabia animal model market, by end user

7.5.2.3. South Africa

7.5.2.3.1. South Africa animal model market, by animal type
7.5.2.3.2. South Africa animal model market, by application
7.5.2.3.3. South Africa animal model market, by end user

7.5.2.4. Rest of LAMEA

7.5.2.4.1. Rest of LAMEA animal model market, by animal type
7.5.2.4.2. Rest of LAMEA animal model market, by application
7.5.2.4.3. Rest of LAMEA animal model market, by end user

7.5.3. LAMEA market size and forecast, by animal type
7.5.4. LAMEA market size and forecast, by application
7.5.5. LAMEA market size and forecast, by end user

CHAPTER 8: COMPANY PROFILES

8.1. Charles River Laboratories International, Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance

8.2. Envigo

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Key strategic moves and developments

8.3. Eurofins Scientific SE

8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance

8.4. GenOway S.A.

8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments

8.5. Hera BioLabs (Transposagen Biopharmaceuticals)

8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio

8.6. JSR Corporation (Crown Bioscience Inc.)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments

8.7. Ozgene Pty Ltd.

8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio

8.8. PerkinElmer, Inc. (Horizon Discovery Group plc.)

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance

8.9. Taconic Biosciences

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments

8.10. The Jackson Laboratory

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments

LIST OF TABLES

TABLE 01. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020-2030 ($MILLION)
TABLE 02. RAT ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 03. MICE ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 04. GUINEA PIGS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 05. RABBITS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 06. OTHERS ANIMAL MODEL MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 07. ANIMAL MODEL MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 08. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2020-2030 ($MILLION)
TABLE 09. ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 10. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY REGION, 2020-2030 ($MILLION)
TABLE 11. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 12. ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY REGION, 2020-2030 ($MILLION)
TABLE 13. ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 14. ANIMAL MODEL MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 15. ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY REGION, 2020-2030 ($MILLION)
TABLE 16. ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2020-2030 ($MILLION)
TABLE 17. ANIMAL MODEL MARKET FOR OTHER END USER, BY REGION, 2020-2030 ($MILLION)
TABLE 18. ANIMAL MODEL MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20. U.S. ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 21. U.S. ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 22. U.S. ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. CANADA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 24. CANADA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 25. CANADA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. MEXICO ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 27. MEXICO ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 28. MEXICO ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. NORTH AMERICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 30. NORTH AMERICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 31. NORTH AMERICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32. EUROPE ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 33. GERMANY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 34. GERMANY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 35. GERMANY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. FRANCE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 37. FRANCE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 38. FRANCE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. UK ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 40. UK ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 41. UK ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. ITALY ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 43. ITALY ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 44. ITALY ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. SPAIN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 46. SPAIN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 47. SPAIN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. REST OF EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 49. REST OF EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 50. REST OF EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. EUROPE ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 52. EUROPE ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 53. EUROPE ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54. ASIA-PACIFIC ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55. JAPAN ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 56. JAPAN ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 57. JAPAN ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. CHINA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 59. CHINA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 60. CHINA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. INDIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 65. INDIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 66. INDIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. SOUTH KOREA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 68. SOUTH KOREA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 69. SOUTH KOREA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. ASIA-PACIFIC ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 74. ASIA-PACIFIC ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 75. ASIA-PACIFIC ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76. LAMEA ANIMAL MODEL MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77. BRAZIL ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 78. BRAZIL ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 79. BRAZIL ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SAUDI ARABIA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 81. SAUDI ARABIA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 82. SAUDI ARABIA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. SOUTH AFRICA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 84. SOUTH AFRICA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 85. SOUTH AFRICA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. REST OF LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 87. REST OF LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 88. REST OF LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89. LAMEA ANIMAL MODEL MARKET, BY ANIMAL TYPE, 2020–2030 ($MILLION)
TABLE 90. LAMEA ANIMAL MODEL MARKET, BY APPLICATION, 2020–2030 ($MILLION)
TABLE 91. LAMEA ANIMAL MODEL MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 92. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY SNAPSHOT
TABLE 93. CHARLES RIVER LABORATORIES INTERNATIONAL: OPERATING SEGMENTS
TABLE 94. CHARLES RIVER LABORATORIES INTERNATIONAL: PRODUCT PORTFOLIO
TABLE 95. ENVIGO: COMPANY SNAPSHOT
TABLE 96. ENVIGO: OERATING SEGMENT
TABLE 97. ENVIGO: PRODUCT PORTFOLIO
TABLE 98. ENVIGO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. EUROFINS: COMPANY SNAPSHOT
TABLE 100. EUROFINS: OPERATING SEGMENTS
TABLE 101. EUROFINS: PRODUCT PORTFOLIO
TABLE 102. GENOWAY S.A.: COMPANY SNAPSHOT
TABLE 103. GENOWAY S.A.: OERATING SEGMENT
TABLE 104. GENOWAY S.A.: PRODUCT PORTFOLIO
TABLE 105. GENOWAY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 106. HERA BIOLABS: COMPANY SNAPSHOT
TABLE 107. HERA BIOLABS: OERATING SEGMENT
TABLE 108. HERA BIOLABS: PRODUCT PORTFOLIO
TABLE 109. JSR CORPORATION: COMPANY SNAPSHOT
TABLE 110. JSR CORPORATION: OERATING SEGMENT
TABLE 111. JSR CORPORATION: PRODUCT PORTFOLIO
TABLE 112. CROWNBIO: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. OZGENE PTY LTD.: COMPANY SNAPSHOT
TABLE 114. OZGENE PTY LTD.: OPERATING SEGMENTS
TABLE 115. OZGENE PTY LTD.: PRODUCT PORTFOLIO
TABLE 116. PERKINELMER, INC.: COMPANY SNAPSHOT
TABLE 117. PERKINELMER, INC.: OPERATING SEGMENTS
TABLE 118. PERKINELMER, INC.: PRODUCT PORTFOLIO
TABLE 119. TACONIC BIOSCIENCES: COMPANY SNAPSHOT
TABLE 120. TACONIC BIOSCIENCES: OPERATING SEGMENTS
TABLE 121. TACONIC BIOSCIENCES: PRODUCT PORTFOLIO
TABLE 122. TACONIC BIOSCIENCES: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. THE JACKSON LABORATORY: COMPANY SNAPSHOT
TABLE 124. THE JACKSON LABORATORY: OPERATING SEGMENT
TABLE 125. THE JACKSON LABORATORY.: PRODUCT PORTFOLIO
TABLE 126. THE JACKSON LABORATORY: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 01. ANIMAL MODEL MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTES
FIGURE 09. HIGH THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE ANALYSIS OF RAT ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. COMPARATIVE ANALYSIS OF MICE ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15. COMPARATIVE ANALYSIS OF GUINEA PIGS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16. COMPARATIVE ANALYSIS OF RABBITS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE ANALYSIS OF OTHERS ANIMAL MODEL MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR BASIC RESEARCH, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR PHARMA & BIOTECH COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF ANIMAL MODEL MARKET FOR OTHER END USER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 25. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 26. CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 27. EUROFINS: NET SALES, 2018–2020 ($MILLION)
FIGURE 28. EUROFINS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 29. GENOWAY S.A.: NET SALES, 2018–2020 ($MILLION)
FIGURE 30. GENOWAY S.A.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31. JSR CORPORATION: NET SALES, 2018–2020 ($MILLION)
FIGURE 32. JSR CORPORATION: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. PERKINELMER, INC.: NET SALES, 2018–2020 ($MILLION)
FIGURE 34. PERKINELMER, INC.: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 35. PERKINELMER, INC.: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 36. THE JACKSON LABORATORY: NET SALES, 2017–2019 ($MILLION)

 
 

Animal model is a non-human species, which is widely researched & studied to understand particular human biological phenomena. Animal models aid researchers & scientists to find cures for various diseases and development of new drugs.

Factors, such as rise in number of chronic diseases across the globe, side effects of medicines, requirement for new therapeutic drugs & vaccines, rise in usage of animal models in virology & infectious diseases, surge in implications of mouse clinical trials (MCTs), and increase in demand for personalized medicine, are expected to drive the growth of the animal model market. Moreover, rise in R&D expenditure in the pharmaceutical & biopharmaceutical industry and surge in adoption of humanized mice models further boost the growth of the market. However, regulations and laws for ethical use of animals in research are expected to restrain the growth of the animal model market.

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,   
Int'l : +1-503-894-6022
( Europe )
+ 44-845-528-1300
Drop us an email at
help@alliedmarketresearch.com

FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Animal Model market is $1,468.7 million in 2020.

A. The forcast period for Animal Model market is 2021 to 2030

A. The market value of Animal Model market in 2021 is $1,577.3 million.

A. The base year is 2020 in Animal Model market

A. Top companies such as Charles River Laboratories, The the Jackson Laboratory, GenOway S.A., Taconic Biosciences, Inc., Envigo, PerkinElmer, Inc. (Horizon Discovery Group plc.), and JSR Corporation (Crown Bioscience Inc.) held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Rat segment is the most influencing segment owing to increase in usage of rat models to study several complex disorders, rise in demand for rat model in biomedical research for understanding the existing health issues, and rise in the advancements in gene editing tools, drives the growth of the market. In addition, surge in consumption of personalized medicine in developing & developed countries, continuous support by governments in the form of investments & grants, and technological advancements in gene editing tools further drives the growth of the market.

A. Increase in demand for animal model to perform various studies on the diseases and human physiology, increase in awareness among researchers about the physiological similarities between humans & animals, rise in importance of genetics in biomedical studies, surge in preference of animal testing in R&D, and rise in usage of animal models in the pre-clinical development by several research laboratories and biopharmaceutical industries are the major factors that boost the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to the increase in research on biomedical and regenerative medicine, increase in awareness related to animal models, and availability of trained medical professionals.

A. The animal in which biological and pathological studies are done & tested is known as an animal model

A. Animal Models are used to study the development & advancement of various diseases and test new treatment methods before conducting human trials

Allied Market Research Allied Market Research Allied Market Research

RELATED TAGS

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Animal Model Market

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Start reading instantly.
    This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

    Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers